Conditions: Healthy
Allocation: NON_RANDOMIZED | Intervention model: SINGLE_GROUP
Enrollment: 12
Healthy volunteers: yes

Brief summary:
The study involves one dose of LY3039478 given by mouth followed by an intravenous infusion (IV) (via a tube linked to a small needle in the vein) of LY3039478. The results of this study will help to answer the following research questions:

* How much LY3039478 gets into the blood stream when given by mouth as a capsule compared to when given by an IV
* How long it takes the body to remove the study drug
* The safety of LY3039478 and any side effects that might be associated with it

Participation in the study is expected to last up to 7 weeks. There will be screening, a single study period, and a follow-up.

Detailed description:

Arms:
arm 1: LY3039478 given once, orally arm 2: 13C 15N 2H-LY3039478 given once, IV

Interventions: intervention 1: LY3039478 intervention 2: 13C 15N 2H-LY3039478 IV
Intervention descriptions: intervention 1: Administered orally intervention 2: Administered IV

Protocol document: